JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY)

• Articles • Previous Articles     Next Articles

Extracapsular cataract extraction combined with goniosynechialysis for acute angle closure glaucoma

LIU Yong-mei1, TIAN Xu2, ZHANG Shuang1, ZHANG Lin-na1   

  1. Department of Ophthalmology, 1. Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;2. Shandong University Hospital, Jinan 250061, Shandong, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2007-06-24 Published:2007-06-24
  • Contact: LIU Yong-mei

PDF (PC)

1811

Abstract: Objective: To investigate the clinical effect of extracapsular cataract extraction combined with goniosynechialysis in treatment of acute angle closure glaucoma with cataract. Methods: Thirty-four patients (37 eyes) were subjected to this management. The anterior chamber depth, visual acuity, configuration of chamber anger, and intraocular pressure were determined. Results: After a mean postoperative follow-up of 180 days, the best corrected visual acuity was improved in 28 cases (30 eyes). The mean anterior chamber depth was 1.674±0.478 mm pre-operatively and 3.412±0.169 mm at post-operative 30 days (t=6.743, P＜0.001). The intraocular pressure was decreased from a pre-operative of 28.436±3.325 mmHg to a postoperative 7-day of 13.983±5.196 mmHg (t=5.263, P＜0.001). Angles of the anterior chamber were opened at post-operative 30 days in all 34 patients. The visual field was not significantly changed in 15 patients at six months after operation. Conclusion: Extracapsular cataract extraction combined with lysis of the synechiae is safe and effective for acute angle closure glaucoma.

Key words: Extracapsular cataract extraction, Goniosynechialysis, Glaucoma, Angle-closure

CLC Number: 

  • R777.4
[1] WANG Xinmeng, JI Junya, YU Haonan, FU Hongchen, WANG Xiang, ZHENG Zekun, LI Yan, ZHONG Yingying. Analysis of refractive prediction accuracy after phacoemulsification combined with goniosynechialysis in acute Angle closure glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 74-79.
[2] YANG Zhen, MENG Sukun, ZHANG Chun. Ophthalmotonic consensual reaction in the fellow eye following unilateral trabectome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 43-51.
[3] LI Yang, MA Ping, ZHANG Han. Effect of different Glaucoma surgery on induced astigmatism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 137-143.
[4] DING Xiaomin, CUI Yan. Advances in severe acute respiratory syndrome coronavirus 2 study about ophthalmology [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 122-127.
[5] MENG Sukun, ZHANG Chun. Long-term progress of visual field defect for open-angle glaucoma patients with ab interno trabeculotomy with the trabectome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 139-148.
[6] HE Meng, TANG Li. Application progress of telemedicine in the management of glaucoma diagnosis and treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 187-195.
[7] ZHANG Yi, TANG Li. Oculocerebrorenal syndrome of lowe with glaucoma: a case report [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 93-97.
[8] ZHONG Yu, LIAO Zhimin, DUAN Xuanchu. Progress in the applications of XEN microstent in glaucoma surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 145-151.
[9] SHI Boying, LIANG Hao, LI Yihong, TANG Dongyong. Surgical treatment of a cataract complicated by anti-glaucoma surgery in an adult patient with Blau syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 60-65.
[10] LIU Lele, KONG XiangyunOverview,SHEN JiaquanGuidance. Progress of cyclodestructive surgeries for treating glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 123-128.
[11] TANG Feiran, KONG XiangyunOverview,SHEN JiaquanGuidance. Research progress in the role of OCTA in measuring superficial peripapillary vessel density in the diagnosis and treatment of glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 77-82.
[12] ZHAO Ying, ZHANG ShanOverview,XU Jiajun, ZHAO JingruGuidance. Research progress on the protective mechanism of heat shock protein 72 in glaucoma retinal ganglion cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 83-87.
[13] ObjectiveTo discuss the causes and appropriate treatment for iris neovascularization following the analysis of cases( eyes). MethodsIt was a retrospective case series study involving patients( eyes)with iris neovascularization diagnosed between September and July . All the patients underwent ophthalmic examination, and all the examination findings and treatments were recorded. The causes, correlative factors, and treatment outcomes of iris neovascularization were analyzed. ResultsOf the patients, ( eyes, .%)had retinal ischemic signs, including vitreous hemorrhage and retinal vascularization on fundus fluorescein angiography, ( eyes, .%)did not have retinal ischemic signs. After months of treatment, retinal vascularization resolved in all the cases, and iris neovascularization resolved completely in patients( eyes, .%), iris neovascularization was still found in patients( eyes, .%). ConclusionsAnterior segment ischemia may also lead to iris vascularization, although retinal ischemia was the main cause. Additionally, iris neovascularization may not always resolve with treatment for retinal ischemia. Finally, anti-VEGF drug injection was an effective treatment for iris neovascularization.. Case analysis of 25 cases of iris neovascularizationLI Xuan1,2, HUANG Yingxiang2 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; 2. Department of Fundus Disease and Eye Trauma, Eye Hospital China Academy of Chinese Medicine Sciences, Beijing 100040, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 41-47.
[14] ObjectiveTo discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. MethodsThe medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. ResultsAfter three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. ConclusionOcular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.. Neovascular glaucoma in ocular ischemic syndrome: a case report and literature reviewQIN Shuqi1, WANG Luping1, JIANG Bin2, WANG Yanling1 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, China; 2. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 53-55.
[15] Ruibao LIU,Ying ZHAO,Minglu GUO,Yu DUAN,Yanxia WU,Xuejing LU. Autophagy and its research progress in glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 158-161.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd